ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for CARIS SCIENCE, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 17, 2015 | $10,000 | Replaced |
| 2nd Quarter - Amendment | Oct 16, 2015 | $10,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | — |
Medicare/Medicaid MMM
Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.